Company intelligence / Profile preview

Changsha Lixing Pharmaceutical Technology Development

Changsha, Hunan, China

Ownership: Private
Development stage: Other

Overview

Changsha Lixing Pharmaceutical Technology Development is a specialized chemical and pharmaceutical technology company based in Changsha, China. The company focuses on the research, development, and production of high-quality pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and fine chemicals. Serving as a CRO and CDMO partner, it provides custom synthesis and process optimization services to global pharmaceutical and biotechnology firms. Their product catalog features a wide range of heterocyclic compounds, boronic acids, and specialized reagents essential for early-stage drug discovery and development.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Changsha Lixing Pharmaceutical Technology Development.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Changsha Lixing Pharmaceutical Technology Development.

Explore the full profile